ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Operating cash flow 2018–2025
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$74.3MFY2025 · since FY2018: -$20.8M → -$74.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$74.3M | -24.3% |
| FY2024 | -$59.7M | -230.1% |
| FY2023 | -$18.1M | -156.6% |
| FY2022 | $32.0M | +123.7% |
| FY2021 | -$135.0M | -215.1% |
| FY2020 | -$42.9M | -565.0% |
| FY2019 | -$6.4M | +69.0% |
| FY2018 | -$20.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARCT financial trends
ARCT RevenueARCT Net incomeARCT Net marginARCT Gross profitARCT Gross marginARCT Operating incomeARCT Operating marginARCT Free cash flowARCT Capital expendituresARCT Return on equityARCT Stock buybacksARCT Dividends paidARCT Total assetsARCT Total liabilitiesARCT Shareholders’ equityARCT overview →